Chan Brian T, Weiser Sheri D, Boum Yap, Siedner Mark J, Mocello A Rain, Haberer Jessica E, Hunt Peter W, Martin Jeffrey N, Mayer Kenneth H, Bangsberg David R, Tsai Alexander C
aDivision of Infectious Diseases, Massachusetts General Hospital bDivision of Infectious Diseases, Brigham and Women's Hospital cHarvard Medical School, Boston, Massachusetts dDivision of HIV/AIDS, San Francisco General Hospital, University of California at San Francisco (UCSF) eCenter for AIDS Prevention Studies, UCSF, San Francisco, California, USA fEpicentre, Mbarara, Uganda gMassachusetts General Hospital Center for Global Health, Boston, Massachusetts hDepartment of Epidemiology and Biostatistics, UCSF, San Francisco, California iDivision of Infectious Diseases, Beth Israel Deaconess Medical Center jFenway Health, Boston, Massachusetts, USA kMbarara University of Science and Technology, Mbarara, Uganda lChester M. Pierce, MD Division of Global Psychiatry, Massachusetts General Hospital, Boston, Massachusetts, USA.
AIDS. 2015 Jan 2;29(1):83-90. doi: 10.1097/QAD.0000000000000495.
Programme implementers have argued that the increasing availability of antiretroviral therapy (ART) will reduce the stigma of HIV. We analyzed data from Uganda to assess how HIV-related stigma has changed during a period of ART expansion.
Serial cross-sectional surveys.
We analyzed data from the Uganda AIDS Rural Treatment Outcomes study during 2007-2012 to estimate trends in internalized stigma among people living with HIV (PLHIV) at the time of treatment initiation. We analyzed data from the Uganda Demographic and Health Surveys from 2006 to 2011 to estimate trends in stigmatizing attitudes and anticipated stigma in the general population. We fitted regression models adjusted for sociodemographic characteristics, with year of data collection as the primary explanatory variable.
We estimated an upward trend in internalized stigma among PLHIV presenting for treatment initiation [adjusted b = 0.18; 95% confidence interval (CI), 0.06-0.30]. In the general population, the odds of reporting anticipated stigma were greater in 2011 compared with 2006 [adjusted odds ratio (OR) = 1.80; 95% CI, 1.51-2.13], despite an apparent decline in stigmatizing attitudes (adjusted OR = 0.62; 95% CI, 0.52-0.74).
Internalized stigma has increased over time among PLHIV in the setting of worsening anticipated stigma in the general population. Further study is needed to better understand the reasons for increasing HIV-related stigma in Uganda and its impact on HIV prevention efforts.
项目实施者认为抗逆转录病毒疗法(ART)可用性的增加将减少对艾滋病毒的污名化。我们分析了乌干达的数据,以评估在ART推广期间与艾滋病毒相关的污名化是如何变化的。
系列横断面调查。
我们分析了2007 - 2012年乌干达艾滋病农村治疗结果研究的数据,以估计开始治疗时艾滋病毒感染者(PLHIV)内化污名的趋势。我们分析了2006年至2011年乌干达人口与健康调查的数据,以估计普通人群中污名化态度和预期污名的趋势。我们拟合了针对社会人口学特征进行调整的回归模型,将数据收集年份作为主要解释变量。
我们估计开始治疗的PLHIV内化污名呈上升趋势[调整后b = 0.18;95%置信区间(CI),0.06 - 0.30]。在普通人群中,尽管污名化态度明显下降(调整后比值比(OR)= 0.62;95% CI,0.52 - 0.74),但2011年报告预期污名的几率高于2006年[调整后OR = 1.80;95% CI,1.51 - 2.13]。
在普通人群预期污名化加剧的背景下,PLHIV的内化污名随时间增加。需要进一步研究以更好地理解乌干达与艾滋病毒相关污名化增加的原因及其对艾滋病毒预防工作的影响。